USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF.
Jurisic A, Sung PJ, Wappett M, Daubriac J, Lobb IT, Kung WW, Crawford N, Page N, Cassidy E, Feutren-Burton S, Rountree JSS, Helm MD, O'Dowd CR, Kennedy RD, Gavory G, Cranston AN, Longley DB, Jacq X, Harrison T.
Jurisic A, et al.
Clin Transl Med. 2024 Apr;14(4):e1648. doi: 10.1002/ctm2.1648.
Clin Transl Med. 2024.
PMID: 38602256
Free PMC article.